Zotarolimus-Eluting stent Non-Inferior to the Paclitaxel-Eluting Stent in Target Vessel Failure, but a Trend Toward Higher Stent Thrombosis is Observed with Zotarolimus: Results of ENDEAVOR 4 Trial: Revision history

Jump to navigation Jump to search
No matching revisions were found.